LOREBLOK HCT

Q: Is this product safe to consume?

No. This product has been recalled due to: Detection of contamination: N-nitroso-N-methylamino-butyric acid (NMBA) in the active substance losartan. Potential effects: long-term carcinogenic risk.

Detection of contamination: N-nitroso-N-methylamino-butyric acid (NMBA) in the active substance losartan. Potential effects: long-term carcinogenic risk.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

App Store Google Play

Risk Level

Critical

Manufacturer

Orion Corporation z siedzibą w Finlandii

Recall Date

01.02.2019

What You Should Know

Recommendations

Do not use affected batches; return remaining packs to the pharmacy; check batch numbers; consult a doctor or pharmacist if concerned.

Actions Taken

Decision of the Chief Pharmaceutical Inspector to withdraw/prohibit placing on the market batches of Loreblok and Loreblok HCT containing losartan from Hetero Labs Limited; decision made immediately e...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?

No. This product has been recalled due to: Detection of contamination: N-nitroso-N-methylamino-butyric acid (NMBA) in the active substance losartan. Potential effects: long-term carcinogenic risk.

What should I do if I already bought this?

Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.

Which batches are affected?

Check the official report for specific batch details.

LOREBLOK HCT

What You Should Know

Recommendations

Actions Taken

Need Help?

Frequently Asked Questions

Other Recalled Products

Lorafen

Carmustine Accord

Taromentin

Plerixafor MSN

Zoledronic Acid Noridem